carbenoxolone sodium has been researched along with Substance-Related Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charkhpour, M; Ghaderi, M; Ghavimi, H; Hassanzadeh, K; Moradi, S; Motahari, R | 1 |
1 trial(s) available for carbenoxolone sodium and Substance-Related Disorders
| Article | Year |
|---|---|
Gap junction blockers: a potential approach to attenuate morphine withdrawal symptoms.
Topics: Animals; Carbenoxolone; Dose-Response Relationship, Drug; Infusions, Intraventricular; Male; Mefloquine; Morphine; Morphine Dependence; Neuroprotective Agents; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Substance-Related Disorders | 2013 |